CD200 and cancer: C1QBP stabilizes the MRE11 protein by forming an MRC complex with MRE11/RAD50 and inhibiting MRE11 exonuclease activity, thereby demonstrating that C1QBP plays a crucial role in the DNA damage response and serves as a potential target for cancer therapeutics (Bai et al., 2019).